| Nome |
# |
|
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth, file e14fb26d-1614-3de1-e053-1705fe0ac030
|
175
|
|
Juxtaglomerular cell tumor of the kidney, file e14fb267-a371-3de1-e053-1705fe0ac030
|
164
|
|
Effect of calcium infusion on the renin-aldosterone system and the calcium-regulating hormones in primary aldosteronism, file e14fb267-6207-3de1-e053-1705fe0ac030
|
162
|
|
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort, file e14fb26a-1335-3de1-e053-1705fe0ac030
|
161
|
|
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo, file e14fb268-18f3-3de1-e053-1705fe0ac030
|
108
|
|
null, file e14fb269-8864-3de1-e053-1705fe0ac030
|
108
|
|
Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth, file e14fb26a-15f0-3de1-e053-1705fe0ac030
|
102
|
|
Aldosterone effects on glomerular structure and function, file e14fb268-38e4-3de1-e053-1705fe0ac030
|
100
|
|
Hyperaldosteronism: Screening and Diagnostic Tests, file e14fb269-52f2-3de1-e053-1705fe0ac030
|
58
|
|
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension., file e14fb267-9bfb-3de1-e053-1705fe0ac030
|
47
|
|
The metabolic syndrome in primary aldosteronism., file e14fb267-a535-3de1-e053-1705fe0ac030
|
41
|
|
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis, file e14fb267-91a5-3de1-e053-1705fe0ac030
|
33
|
|
Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study, file e14fb267-614b-3de1-e053-1705fe0ac030
|
31
|
|
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase, file e14fb267-6206-3de1-e053-1705fe0ac030
|
30
|
|
Ambulatory Arterial Stiffness Indexes in Cushing’s Syndrome, file e14fb269-8c83-3de1-e053-1705fe0ac030
|
23
|
|
Monogenic low renin hypertension, file e14fb267-8538-3de1-e053-1705fe0ac030
|
22
|
|
Guidelines versus real life practice: the case of colonoscopy in acromegaly, file e14fb26a-1e7e-3de1-e053-1705fe0ac030
|
21
|
|
1?,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer., file e14fb267-b075-3de1-e053-1705fe0ac030
|
19
|
|
Multiple endocrine neoplasia type 1 and adrenal lesions, file e14fb267-9301-3de1-e053-1705fe0ac030
|
18
|
|
Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension., file e14fb267-a548-3de1-e053-1705fe0ac030
|
18
|
|
Left ventricular geometry and 24-h blood pressure profile in Cushing’s syndrome, file e14fb269-54a6-3de1-e053-1705fe0ac030
|
17
|
|
Psychological aspects of primary aldosteronism, file e14fb267-89f9-3de1-e053-1705fe0ac030
|
15
|
|
Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency., file e14fb267-8fcd-3de1-e053-1705fe0ac030
|
15
|
|
2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy : From Global Cardiovascular Risk Stratification to Combination Therapy., file e14fb267-a908-3de1-e053-1705fe0ac030
|
15
|
|
Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues, file e14fb267-c895-3de1-e053-1705fe0ac030
|
15
|
|
Effetti extra-renali dei mineralcorticoidi: non solo sale!, file e14fb26a-5097-3de1-e053-1705fe0ac030
|
14
|
|
Cardiovascular autonomic function in Cushing's syndrome, file e14fb267-8590-3de1-e053-1705fe0ac030
|
13
|
|
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates., file e14fb267-9b3c-3de1-e053-1705fe0ac030
|
13
|
|
Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy, file e14fb26a-7b83-3de1-e053-1705fe0ac030
|
13
|
|
Coronary microvascular function in patients with Cushing's syndrome., file e14fb267-a547-3de1-e053-1705fe0ac030
|
12
|
|
Risk factors and long-term outcome in pituitary-dependent Cushing's disease, file e14fb267-6156-3de1-e053-1705fe0ac030
|
11
|
|
Risk factors and long-term follow-up of adrenal incidentalomas, file e14fb267-8e81-3de1-e053-1705fe0ac030
|
11
|
|
National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities., file e14fb267-b41a-3de1-e053-1705fe0ac030
|
11
|
|
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions, file e14fb268-8d27-3de1-e053-1705fe0ac030
|
11
|
|
Methylation status of Vitamin D receptor gene promoter in benign and malignant adrenal tumors, file e14fb26c-ab2a-3de1-e053-1705fe0ac030
|
11
|
|
Determinants of healing among patients with COVID-19: The results of the SARS-RAS study of the Italian Society of Hypertension, file e14fb26f-a89c-3de1-e053-1705fe0ac030
|
11
|
|
Comment - Is there a role for low doses of mitotane (o,p '-DDD) as adjuvant therapy in adrenocortical carcinoma?, file e14fb267-627d-3de1-e053-1705fe0ac030
|
10
|
|
Aldosterone does not modify gene expression in human endothelial cells, file e14fb267-a347-3de1-e053-1705fe0ac030
|
10
|
|
The effects of mitotane and 1α,25-dihydroxyvitamin D3 on Wnt/beta-catenin signaling in human adrenocortical carcinoma cells, file e14fb26c-5e52-3de1-e053-1705fe0ac030
|
10
|
|
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism., file e14fb267-60a1-3de1-e053-1705fe0ac030
|
9
|
|
Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension, file e14fb267-a601-3de1-e053-1705fe0ac030
|
9
|
|
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome., file e14fb267-ab66-3de1-e053-1705fe0ac030
|
9
|
|
Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome, file e14fb269-57b6-3de1-e053-1705fe0ac030
|
9
|
|
Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the italian society of hypertension, file e14fb270-0bc0-3de1-e053-1705fe0ac030
|
9
|
|
Renin-Angiotensin Mechanism., file e14fb267-66cd-3de1-e053-1705fe0ac030
|
8
|
|
The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience, file e14fb267-82bd-3de1-e053-1705fe0ac030
|
8
|
|
Psychosocial impairment in patients treated for pituitary disease: a controlled study, file e14fb267-873e-3de1-e053-1705fe0ac030
|
8
|
|
Expression of aromatase and estrogen receptors in human adrenocortical tumors, file e14fb267-88c1-3de1-e053-1705fe0ac030
|
8
|
|
Psychological Assessment of Primary Aldosteronism: A Controlled Study, file e14fb267-8938-3de1-e053-1705fe0ac030
|
8
|
|
Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension., file e14fb267-9d3a-3de1-e053-1705fe0ac030
|
8
|
|
Relationship between Bone Formation Markers Bone Alkaline Phosphatase, Osteocalcin and Amino-terminal Propeptide of Type I Collagen and Bone Mineral Density in Elderly Men. Preliminary Results., file e14fb267-a138-3de1-e053-1705fe0ac030
|
8
|
|
A case of nephrotic syndrome hidden by Cushing's disease., file e14fb267-abca-3de1-e053-1705fe0ac030
|
8
|
|
The effect of sodium intake on angiotensin content in the rat adrenal gland., file e14fb267-60da-3de1-e053-1705fe0ac030
|
7
|
|
In vitro evidence for local generation of renin and angiotensin II/III immunoreactivity by the human adrenal gland, file e14fb267-60dc-3de1-e053-1705fe0ac030
|
7
|
|
24-HOUR BLOOD-PRESSURE PROFILE IN ADDISONS-DISEASE, file e14fb267-9010-3de1-e053-1705fe0ac030
|
7
|
|
Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study, file e14fb267-ad66-3de1-e053-1705fe0ac030
|
7
|
|
Evolution of computed tomography-detectable adrenal nodules in patients with bilateral primary aldosteronism, file e14fb269-4d2a-3de1-e053-1705fe0ac030
|
7
|
|
Adrenal incidentaloma in pregnancy: clinical, molecular and immunohistochemical findings, file e14fb267-6baa-3de1-e053-1705fe0ac030
|
6
|
|
P450c17 DEFICIENCY: CLINICAL AND MOLECULAR CHARACTERIZATION OF SIX PATIENTS., file e14fb267-8c7f-3de1-e053-1705fe0ac030
|
6
|
|
Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients, file e14fb267-97a6-3de1-e053-1705fe0ac030
|
6
|
|
Ambulatory arterial stiffness indexes in acromegaly, file e14fb267-9bc2-3de1-e053-1705fe0ac030
|
6
|
|
Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism, file e14fb26b-2b2a-3de1-e053-1705fe0ac030
|
6
|
|
Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study, file e14fb26c-4108-3de1-e053-1705fe0ac030
|
6
|
|
Effect of digoxin on the in vitro secretion of renin and angiotensin II/III immunoreactivity by the human adrenal gland, file e14fb267-60dd-3de1-e053-1705fe0ac030
|
5
|
|
Plasma adiponectin is decreased in nonalcoholic fatty liver disease., file e14fb267-88b6-3de1-e053-1705fe0ac030
|
5
|
|
Comparison of confirmatory tests for the diagnosis of primary aldosteronism, file e14fb267-89f7-3de1-e053-1705fe0ac030
|
5
|
|
Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome, file e14fb267-8e69-3de1-e053-1705fe0ac030
|
5
|
|
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone., file e14fb267-9e84-3de1-e053-1705fe0ac030
|
5
|
|
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series, file e14fb269-87e2-3de1-e053-1705fe0ac030
|
5
|
|
Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism, file e14fb269-9b22-3de1-e053-1705fe0ac030
|
5
|
|
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism, file 2d2e70ff-2ec7-452e-90b4-a05b090b3146
|
4
|
|
Nonalcoholic Fatty Liver Disease in Primary Aldosteronism: A Pilot Study, file e14fb267-8784-3de1-e053-1705fe0ac030
|
4
|
|
Ultrasound evaluation of carotid artery in primary hyperparathyroidism, file e14fb267-8d13-3de1-e053-1705fe0ac030
|
4
|
|
CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism., file e14fb267-90a7-3de1-e053-1705fe0ac030
|
4
|
|
Inactivation of the p16 tumor suppressor gene in adrenocortical tumors, file e14fb267-93de-3de1-e053-1705fe0ac030
|
4
|
|
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism., file e14fb267-9ba0-3de1-e053-1705fe0ac030
|
4
|
|
Coronary Microvascular Dysfunction Induced by Primary Hyperparathyroidism is Restored after Parathyroidectomy., file e14fb267-a01b-3de1-e053-1705fe0ac030
|
4
|
|
Targeting Estrogen Receptor- Reduces Adrenocortical Cancer (ACC) Cell Growth in Vitro and in Vivo: Potential Therapeutic Role of Selective Estrogen Receptor Modulators (SERMs) for ACC Treatment, file e14fb267-a0fb-3de1-e053-1705fe0ac030
|
4
|
|
High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage, file e14fb267-a34b-3de1-e053-1705fe0ac030
|
4
|
|
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism, file e14fb26b-49fe-3de1-e053-1705fe0ac030
|
4
|
|
Local renin-angiotensin system in human adrenals and aldosteronomas, file e14fb267-6205-3de1-e053-1705fe0ac030
|
3
|
|
Effect of surgical treatment on hypertension in Cushing's syndrome, file e14fb267-627f-3de1-e053-1705fe0ac030
|
3
|
|
Shift from Conn's syndrome to Cushing's syndrome in a recurrent adrenocortical carcinoma, file e14fb267-8be5-3de1-e053-1705fe0ac030
|
3
|
|
Scintigraphic patterns of adrenocortical carcinoma: morpho-functional correlates, file e14fb267-8efb-3de1-e053-1705fe0ac030
|
3
|
|
Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas, file e14fb267-932a-3de1-e053-1705fe0ac030
|
3
|
|
Development of overt Cushing's syndrome in patients with adrenal incidentaloma, file e14fb267-93e4-3de1-e053-1705fe0ac030
|
3
|
|
Captopril test can give misleading results in patients with suspect primary aldosteronism., file e14fb267-a537-3de1-e053-1705fe0ac030
|
3
|
|
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas., file e14fb267-b014-3de1-e053-1705fe0ac030
|
3
|
|
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma., file e14fb267-b97f-3de1-e053-1705fe0ac030
|
3
|
|
Genetic polymorphism of the renin-angiotensin system and arterial hypertension in the Italian population; the GENIPER project., file e14fb267-60b8-3de1-e053-1705fe0ac030
|
2
|
|
Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT), file e14fb270-0458-3de1-e053-1705fe0ac030
|
2
|
|
Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity in vivo., file e14fb267-61e9-3de1-e053-1705fe0ac030
|
1
|
|
null, file e14fb267-b36e-3de1-e053-1705fe0ac030
|
1
|
|
Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase, file e14fb268-6f03-3de1-e053-1705fe0ac030
|
1
|
|
Reply to letter to the editor âBlood pressure variability in primary hyperparathyroidism: more data neededâ, file e14fb26a-ab4e-3de1-e053-1705fe0ac030
|
1
|
|
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension, file e14fb26d-75d3-3de1-e053-1705fe0ac030
|
1
|
| Totale |
1.970 |